Product image of Hydromorphon Glenmark (Hydromorphone Hydrochloride) supplied by GNH India

Hydromorphon Glenmark

Active Ingredient:
Hydromorphone Hydrochloride
Origin:
EU

Hydromorphon Glenmark (Hydromorphone Hydrochloride)

Hydromorphone Hydrochloride, the active ingredient in Hydromorphon Glenmark, is an opioid analgesic presented as an oral formulation for oral use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient. The medication is supplied in compliance with European Union pharmaceutical standards and is intended for prescription‑only distribution.

GNH India supplies Hydromorphon Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our network ensures reliable sourcing, regulatory adherence, and timely delivery across multiple regions.

Manufacturer / TM Owner

Glenmark Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydromorphone Hydrochloride is an opioid analgesic used to treat pain by acting on the central nervous system.

  • Acute postoperative pain: provides rapid relief after surgical procedures.
  • Cancer‑related pain: helps control severe pain associated with malignant disease.
  • Chronic severe non‑cancer pain: used when other analgesics are inadequate.

How It Works

  • Hydromorphone Hydrochloride binds selectively to the µ‑opioid receptors in the central nervous system, mimicking the action of endogenous opioids. This agonist activity inhibits the transmission of nociceptive signals and alters the perception of pain, producing analgesia and sedation while also affecting respiratory and gastrointestinal motility.

Side Effects

Hydromorphon Glenmark may cause a range of adverse reactions.

Common Side Effects

  • Nausea: feeling of sickness or urge to vomit.
  • Constipation: reduced bowel movements and hard stools.
  • Drowsiness: increased sleepiness or fatigue.
  • Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing that can be life‑threatening.
  • Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
  • Anaphylaxis: rare severe allergic reaction with rash, swelling, and airway compromise.

Precautions & Warnings

Before prescribing Hydromorphon Glenmark, clinicians should consider several safety measures.

  • Assess pain severity: confirm that opioid therapy is appropriate for the patient.
  • Monitor respiratory function: watch for signs of depression, especially after dose changes.
  • Avoid use in severe respiratory disease: patients with COPD or sleep apnea are at higher risk.
  • Caution in renal or hepatic impairment: dose adjustments may be required.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Hydromorphon Glenmark can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Concomitant CNS depressants: increased risk of profound sedation and respiratory depression.
  • MAO inhibitors: may precipitate severe opioid toxicity.

Moderate Interactions (Monitor Closely)

  • SSRIs: potential for serotonin syndrome when combined.
  • Diuretics: may enhance hypotensive effects.
  • Anticholinergics: can worsen opioid‑induced constipation.

Frequently Asked Questions

Hydromorphon Glenmark contains hydromorphone hydrochloride, an opioid analgesic prescribed for the management of moderate to severe pain, such as postoperative pain, cancer‑related pain, or chronic pain that has not responded to less potent analgesics.

Hydromorphone acts as an agonist at µ‑opioid receptors in the brain and spinal cord. By activating these receptors, it blocks the transmission of pain signals and alters the perception of pain, providing both analgesia and sedation.

The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, and individual health factors. Patients should follow the prescriber’s instructions exactly.

Safety in pregnancy and lactation has not been established for hydromorphone. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant, and it should be used only under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Hydromorphone is a potent µ‑opioid receptor agonist, generally considered more potent on a milligram‑for‑milligram basis than morphine. It offers rapid onset of analgesia but shares a similar safety profile, requiring careful monitoring for respiratory depression and dependence.

Store the product at ambient temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and out of reach of children or unauthorized persons.

Hydromorphon Glenmark is formulated for oral use. It is taken by mouth with or without food, according to the prescriber’s instructions, and the tablet should be swallowed whole unless otherwise directed.

The most serious risks include respiratory depression, severe hypotension, and the potential for dependence, abuse, or addiction. Patients should be monitored closely for signs of these events, especially during dose initiation or escalation.

Hydromorphon Glenmark should not be used by individuals with known hypersensitivity to hydromorphone or any component of the formulation, patients with severe respiratory insufficiency, or those taking MAO inhibitors within 14 days. It is also contraindicated in unmonitored opioid‑naïve patients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydromorphone Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT